Published • loading... • Updated
Samsung Epis Holdings Opens Beijing R&D Base
Summary by businesskorea.co.kr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Samsung Epis Holdings Opens Beijing R&D Base
Samsung Bioepis headquarters in Incheon Samsung Epis Holdings announced on May 29 that it recently established ‘Samsung Biotechnology China Co., Ltd.’, a 100% owned subsidiary for the purpose of biopharmaceutical research and development in Changping District, Beijing, China. The newly established ‘Samsung Bioepis China R&D Center’ is the first global research base secured since the launch of Samsung Epis Holdings. Since its launch in November l…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
